Research progress of single-cell sequencing in tuberculosis

Jiahui Pan, Zecheng Chang, Xinyue Zhang, Qinzhou Dong, He Zhao, Jingwei Shi, Guoqing WangFrontiers in Immunology 2023 · DOI

TL;DR

This review explores how single-cell sequencing technologies are moving tuberculosis (TB) research beyond "bulk" averages to reveal the high-resolution cellular landscape of infection. By mapping individual immune cells and their spatial organization, researchers are identifying rare cell populations, novel biomarkers for disease stages, and the specific mechanisms Mycobacterium tuberculosis uses to evade the host immune system.

What Problem Does This Paper Address?

Tuberculosis remains one of the world’s deadliest infectious diseases, yet our understanding of its pathogenesis is surprisingly incomplete. The primary challenge lies in the complexity of the host-pathogen interface. When Mycobacterium tuberculosis (Mtb) infects a host, it triggers the formation of granulomas—complex "walled-off" structures of immune cells.

Traditional "bulk" sequencing methods measure the average gene expression of a tissue sample, which effectively masks the behavior of rare but critical cell types. We haven't fully understood why some immune cells successfully kill the bacteria while others provide a "permissive niche" for them to thrive. This paper reviews how single-cell technologies allow us to "zoom in" on these individual interactions to find new diagnostic markers and therapeutic targets.

Methods

As a review paper, the authors synthesize the development and application of several cutting-edge modalities:

  • scRNA-seq (Single-cell RNA sequencing): The workhorse of the field, used to identify cell heterogeneity and rare populations (like specific NK cell subsets) by measuring the transcriptome of individual cells.
  • scATAC-seq: Used to study chromatin accessibility, revealing how Mtb infection "reprograms" the host's epigenome to suppress immune responses.
  • Spatial Transcriptomics: A newer frontier that preserves the physical location of cells within a tissue slice. This is crucial for TB, as it allows researchers to map the "geography" of a granuloma—identifying which cells are at the necrotic center versus the protective periphery.
  • Single-cell Genome Sequencing: Techniques like MALBAC are used to amplify minute quantities of DNA to study bacterial mutations and evolutionary relationships at the single-cell level.

Datasets

The paper provides a comprehensive meta-analysis of recent high-impact studies (summarized in Table 1). These datasets span:

  • Human Clinical Samples: Bronchoalveolar lavage fluid (BALF), peripheral blood mononuclear cells (PBMCs), and tuberculous pleural effusion (TPE).
  • Animal Models: Rhesus macaques (the gold standard for granuloma study), mice, and zebrafish (used to model macrophage transformation).
  • Newly Highlighted Benchmarks: The review points to specific studies that have established "atlases" of the TB-infected lung, providing a reference for future researchers.

Key Insights and Ideas

  • Macrophage "Permissiveness": Not all macrophages are created equal. scRNA-seq has revealed that alveolar macrophages (AMs) often provide a "permissive niche" where Mtb can establish itself, while interstitial macrophages (IMs) may be more restrictive.
  • The Granuloma as a Micro-Ecosystem: Spatial transcriptomics has shown that granulomas are not just clumps of cells but organized structures with distinct zones. The center often contains transcripts related to immunosuppression, helping the bacteria survive.
  • NK Cells as Diagnostic Beacons: One of the most promising "aha" moments is the discovery that specific Natural Killer (NK) cell subsets (CD3-CD7+GZMB+) are gradually depleted as a patient moves from healthy to latent to active TB. This could lead to a highly precise blood test for disease progression.
  • T Cell Exhaustion: Much like in cancer, chronic TB infection leads to "T cell exhaustion," where the immune system's primary defenders lose their ability to kill. Single-cell mapping shows that severe TB patients suffer from an extensive failure of Th1 and CD8+ T cells.
  • Vaccine "Training": The review highlights that the BCG vaccine doesn't just work on T cells; it performs "trained immunity" by epigenetically reprogramming monocytes to be more effective at the innate level.

Key Results

  • Cellular Diversity: Researchers identified 13 distinct cell subsets within macaque granulomas, showing that "restrictive" granulomas (those that control the bacteria) have a higher abundance of Type 1 and Type 17 T cells.
  • Bacterial Evasion: The paper details how the Mtb protein PknG inhibits host immunity by interfering with the ubiquitin-like domain, a discovery made possible by studying host-pathogen protein-protein interaction networks.
  • Drug Penetration: Spatial analysis revealed that the drugs Rifampicin and Rifapentine penetrate lung cavities differently, explaining why some treatments fail in patients with large lesions.

Limitations and Future Work

The authors identify several "bottlenecks" that still need to be cleared:

  1. The Poly-A Problem: Most scRNA-seq relies on capturing the "poly-A tail" of mRNA. Since Mtb mRNA lacks this tail, it is difficult to sequence the host and the bacteria simultaneously from the same cell.
  2. Binuclear Cells: TB patients often have a high proportion of binuclear cells in their blood, which can confuse standard bioinformatic pipelines designed for single-nucleus data.
  3. Multi-Omics Integration: While we have good transcriptomic data, we need better ways to integrate it with proteomics and metabolomics at the single-cell level to get the "full picture" of the infection.
  4. Clinical Translation: Most spatial data currently comes from animal models; there is an urgent need for more high-resolution spatial mapping of human TB tissues.

Summary updated

Abstract

Tuberculosis is a major infectious disease caused by <i>Mycobacterium tuberculosis</i> infection. The pathogenesis and immune mechanism of tuberculosis are not clear, and it is urgent to find new drugs, diagnosis, and treatment targets. A useful tool in the quest to reveal the enigmas related to <i>Mycobacterium tuberculosis</i> infection and disease is the single-cell sequencing technique. By clarifying cell heterogeneity, identifying pathogenic cell groups, and finding key gene targets, the map at the single cell level enables people to better understand the cell diversity of complex organisms and the immune state of hosts during infection. Here, we briefly reviewed the development of single-cell sequencing, and emphasized the different applications and limitations of various technologies. Single-cell sequencing has been widely used in the study of the pathogenesis and immune response of tuberculosis. We review these works summarizing the most influential findings. Combined with the multi-molecular level and multi-dimensional analysis, we aim to deeply understand the blank and potential future development of the research on <i>Mycobacterium tuberculosis</i> infection using single-cell sequencing technology.
BibTeX
@inproceedings{pan2023research,
  author = {Jiahui Pan and Zecheng Chang and Xinyue Zhang and Qinzhou Dong and He Zhao and Jingwei Shi and Guoqing Wang},
  title = {{Research progress of single-cell sequencing in tuberculosis}},
  booktitle = {Frontiers in Immunology},
  year = {2023},
  doi = {10.3389/fimmu.2023.1276194},
}
Figure